HomeCompareOBLN vs EQR

OBLN vs EQR: Dividend Comparison 2026

OBLN yields 65.57% · EQR yields 4.73%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 OBLN wins by $812.6K in total portfolio value
10 years
OBLN
OBLN
● Live price
65.57%
Share price
$3.05
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$853.1K
Annual income
$213,279.01
Full OBLN calculator →
EQR
EQR
● Live price
4.73%
Share price
$58.58
Annual div
$2.77
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.5K
Annual income
$3,819.61
Full EQR calculator →

Portfolio growth — OBLN vs EQR

📍 OBLN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodOBLNEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, OBLN + EQR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
OBLN pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OBLN
Annual income on $10K today (after 15% tax)
$5,573.77/yr
After 10yr DRIP, annual income (after tax)
$181,287.16/yr
EQR
Annual income on $10K today (after 15% tax)
$401.93/yr
After 10yr DRIP, annual income (after tax)
$3,246.67/yr
At 15% tax rate, OBLN beats the other by $178,040.49/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OBLN + EQR for your $10,000?

OBLN: 50%EQR: 50%
100% EQR50/50100% OBLN
Portfolio after 10yr
$446.8K
Annual income
$108,549.31/yr
Blended yield
24.30%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

OBLN
Analyst Ratings
2
Buy
4
Hold
Consensus: Hold
Altman Z
-22.4
Piotroski
3/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+20.1% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OBLN buys
0
EQR buys
0
No recent congressional trades found for OBLN or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricOBLNEQR
Forward yield65.57%4.73%
Annual dividend / share$2.00$2.77
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8%
Portfolio after 10y$853.1K$40.5K
Annual income after 10y$213,279.01$3,819.61
Total dividends collected$718.9K$16.9K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusHoldHold

Year-by-year: OBLN vs EQR ($10,000, DRIP)

YearOBLN PortfolioOBLN Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$17,257$6,557.38$11,248$547.57+$6.0KOBLN
2$29,041$10,575.99$12,701$666.53+$16.3KOBLN
3$47,708$16,633.36$14,405$814.59+$33.3KOBLN
4$76,584$25,536.82$16,413$999.84+$60.2KOBLN
5$120,257$38,311.84$18,795$1,232.92+$101.5KOBLN
6$184,899$56,223.86$21,639$1,527.95+$163.3KOBLN
7$278,632$80,790.63$25,057$1,903.80+$253.6KOBLN
8$411,919$113,782.33$29,197$2,385.87+$382.7KOBLN
9$597,960$157,206.82$34,250$3,008.70+$563.7KOBLN
10$853,096$213,279.01$40,467$3,819.61+$812.6KOBLN

OBLN vs EQR: Complete Analysis 2026

OBLNStock

Obalon Therapeutics, Inc., a vertically integrated medical device company, focuses on developing and commercializing medical devices to treat people with obesity. The company offers the Obalon Balloon System designed to provide weight loss in patients with obesity. Its Obalon Balloon System comprises of a swallow able capsule that contains an inflatable balloon attached to a microcatheter; the Obalon Navigation System console, which is a combination of hardware and software used to track and display the location of the balloon during placement; the Obalon Touch Inflation Dispenser, which is a semi-automated, hand-held inflation device used to inflate the balloon once it is placed; and a disposable canister filled with mixture of gas. As of February 27, 2020, it had three company-managed retail treatment centers in California. Obalon Therapeutics, Inc. was founded in 2008 and is headquartered in Carlsbad, California.

Full OBLN Calculator →

EQRREIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this OBLN vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OBLN vs SCHDOBLN vs JEPIOBLN vs OOBLN vs KOOBLN vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.